Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification.

Breast cancer research : BCR

Volumn 9, Issue 5, 2007, Pages

  Cayre, Anne ^a   Mishellany, Florence ^a   Lagarde, Nicole ^a   Penault Llorca, Frédérique ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGENIC SUBSTRATE; DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANALYTICAL EQUIPMENT; ARTICLE; BREAST TUMOR; CANCER INVASION; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; PROGNOSIS;

BREAST NEOPLASMS; CHROMOGENIC COMPOUNDS; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASM INVASIVENESS; PROGNOSIS; REAGENT KITS, DIAGNOSTIC; RECEPTOR, ERBB-2;

EID: 40449103809     PISSN: None     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1770     Document Type: Article

References (0)